Literature DB >> 15790922

Tissue type plasminogen activator facilitates NMDA-receptor-mediated retinal apoptosis through an independent fibrinolytic cascade.

Masako Kumada1, Masayuki Niwa, Akira Hara, Hiroyuki Matsuno, Hideki Mori, Shigeru Ueshima, Osamu Matsuo, Tetsuya Yamamoto, Osamu Kozawa.   

Abstract

PURPOSE: To investigate the association between apoptosis and the fibrinolytic system in retinal cell damage.
METHODS: Tissue type plasminogen activator-deficient (tPA(-/-)), urokinase type plasminogen activator-deficient (uPA(-/-)), plasminogen activator inhibitor-1-deficient (PAI-1(-/-)), alpha2 antiplasmin-deficient (alpha2 AP(-/-)) mice, and their wild-type counterparts were used. Retinal cell damage was induced by intravitreal injection of the excitotoxin N-methyl-d-aspartate (NMDA). The TdT-dUTP terminal nick-end labeling (TUNEL) method was used to examine retinal cell damage.
RESULTS: tPA(-/-) mice were resistant to retinal cell damage caused by administration of NMDA, and PAI-1(-/-) mice were more injured than their wild-type. No significant difference was observed between uPA(-/-) or alpha2 AP(-/-) and their wild-type mice.
CONCLUSIONS: The results strongly suggest that endogenous tPA, but not uPA acts as a facilitator in NMDA-induced retinal cell damage, and that its mechanism may not be associated with cleavage of plasminogen into plasmin in the fibrinolytic cascade.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15790922     DOI: 10.1167/iovs.04-0595

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  11 in total

1.  Tissue-type plasminogen activator requires a co-receptor to enhance NMDA receptor function.

Authors:  Andre L Samson; Simon T Nevin; David Croucher; Be'eri Niego; Philip B Daniel; Thomas W Weiss; Eliza Moreno; Denis Monard; Daniel A Lawrence; Robert L Medcalf
Journal:  J Neurochem       Date:  2008-09-15       Impact factor: 5.372

Review 2.  Inducible rodent models of glaucoma.

Authors:  Iok-Hou Pang; Abbot F Clark
Journal:  Prog Retin Eye Res       Date:  2019-09-23       Impact factor: 21.198

3.  Hypoxia inducible factor-1α (HIF-1α) and some HIF-1 target genes are elevated in experimental glaucoma.

Authors:  Ceren Ergorul; Arjun Ray; Wei Huang; Dan Yi Wang; Yixin Ben; Ippolita Cantuti-Castelvetri; Cynthia L Grosskreutz
Journal:  J Mol Neurosci       Date:  2010-03-17       Impact factor: 3.444

4.  Inhibition of plasminogen activators attenuates the death of differentiated retinal ganglion cells and stabilizes their neurite network in vitro.

Authors:  Ronée Harvey; Shravan K Chintala
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-04       Impact factor: 4.799

5.  Mechanisms regulating plasminogen activators in transformed retinal ganglion cells.

Authors:  Nathan Rock; Shravan K Chintala
Journal:  Exp Eye Res       Date:  2008-02-20       Impact factor: 3.467

6.  Decreased Expression of DREAM Promotes the Degeneration of Retinal Neurons.

Authors:  Shravan Chintala; Mei Cheng; Xiao Zhang
Journal:  PLoS One       Date:  2015-05-28       Impact factor: 3.240

Review 7.  Retinal Cell Degeneration in Animal Models.

Authors:  Masayuki Niwa; Hitomi Aoki; Akihiro Hirata; Hiroyuki Tomita; Paul G Green; Akira Hara
Journal:  Int J Mol Sci       Date:  2016-01-15       Impact factor: 5.923

8.  Retinal safety of intravitreal rtPA in healthy rats and under excitotoxic conditions.

Authors:  Alejandra Daruich; Jérôme Parcq; Kimberley Delaunay; Marie-Christine Naud; Quentin Le Rouzic; Emilie Picard; Patricia Crisanti; Denis Vivien; Marianne Berdugo; Francine Behar-Cohen
Journal:  Mol Vis       Date:  2016-11-10       Impact factor: 2.367

9.  Evaluation of Retinal Pigment Epithelial Cell Cytotoxicity of Recombinant Tissue Plasminogen Activator Using Human-Induced Pluripotent Stem Cells.

Authors:  Hiroyuki Kamao; Atsushi Miki; Junichi Kiryu
Journal:  J Ophthalmol       Date:  2019-03-19       Impact factor: 1.909

Review 10.  Current concepts in the pathophysiology of glaucoma.

Authors:  Renu Agarwal; Suresh K Gupta; Puneet Agarwal; Rohit Saxena; Shyam S Agrawal
Journal:  Indian J Ophthalmol       Date:  2009 Jul-Aug       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.